STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia

V Gouilleux-Gruart1, F Gouilleux, C Desaint

  • 1Laboratoire d'Immunologie, Centre Hospitalier Universitaire d'Amiens, France.

Blood
|March 1, 1996
PubMed

Insights

Constitutively activated signal transducers and activators of transcription (STAT) proteins were found in acute leukemia cells. This constitutive activation of STAT factors is likely involved in leukemogenesis.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Oncology

Background:

  • Cytokine-activated signal transduction pathways involve Janus kinases (JAK) and signal transducers and activators of transcription (STAT) factors.
  • Constitutive activation of these pathways is implicated in various cancers.

Purpose of the Study:

  • To investigate the activation status of STAT factors in peripheral blood cells from patients with acute leukemia.
  • To determine if STAT factors are constitutively active in vivo in acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML).

Main Methods:

  • Nuclear extracts from leukemia cells were analyzed using bandshift assays with specific oligonucleotide probes (beta-casein, IRF-1, ISRE).
  • Specificity of DNA-protein complex formation was confirmed using nonradioactive competitors.
  • Supershift experiments with specific antibodies identified the involved STAT proteins (STAT1, STAT3, STAT5).

Main Results:

  • Specific DNA-protein complex formation was observed with beta-casein and IRF-1 promoter probes in ALL and AML cell extracts.
  • STAT5 and STAT1-related factors were detected in ALL.
  • STAT1, STAT3, and STAT5-related proteins were identified in AML.
  • These STAT factors were active without prior cytokine stimulation, indicating constitutive activation.

Conclusions:

  • STAT factors are constitutively activated in peripheral blood cells of patients with acute leukemia (ALL and AML).
  • The constitutive activation of STAT proteins is likely a contributing factor in the development of leukemia (leukemogenesis).

Related Concept Videos

Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...